1. Home
  2. VRAX vs OPTT Comparison

VRAX vs OPTT Comparison

Compare VRAX & OPTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • OPTT
  • Stock Information
  • Founded
  • VRAX 2013
  • OPTT 1984
  • Country
  • VRAX United Kingdom
  • OPTT United States
  • Employees
  • VRAX N/A
  • OPTT N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • OPTT Electric Utilities: Central
  • Sector
  • VRAX Health Care
  • OPTT Utilities
  • Exchange
  • VRAX Nasdaq
  • OPTT Nasdaq
  • Market Cap
  • VRAX 17.2M
  • OPTT 17.2M
  • IPO Year
  • VRAX 2022
  • OPTT 2007
  • Fundamental
  • Price
  • VRAX $2.80
  • OPTT $0.25
  • Analyst Decision
  • VRAX
  • OPTT
  • Analyst Count
  • VRAX 0
  • OPTT 0
  • Target Price
  • VRAX N/A
  • OPTT N/A
  • AVG Volume (30 Days)
  • VRAX 13.0M
  • OPTT 1.8M
  • Earning Date
  • VRAX 11-06-2024
  • OPTT 09-16-2024
  • Dividend Yield
  • VRAX N/A
  • OPTT N/A
  • EPS Growth
  • VRAX N/A
  • OPTT N/A
  • EPS
  • VRAX N/A
  • OPTT N/A
  • Revenue
  • VRAX $156,419.00
  • OPTT $5,525,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • OPTT N/A
  • Revenue Next Year
  • VRAX $66.97
  • OPTT N/A
  • P/E Ratio
  • VRAX N/A
  • OPTT N/A
  • Revenue Growth
  • VRAX 1727.11
  • OPTT 102.23
  • 52 Week Low
  • VRAX $0.60
  • OPTT $0.12
  • 52 Week High
  • VRAX $9.00
  • OPTT $0.57
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.62
  • OPTT 58.91
  • Support Level
  • VRAX $2.40
  • OPTT $0.17
  • Resistance Level
  • VRAX $3.26
  • OPTT $0.19
  • Average True Range (ATR)
  • VRAX 0.75
  • OPTT 0.01
  • MACD
  • VRAX -0.31
  • OPTT 0.01
  • Stochastic Oscillator
  • VRAX 9.18
  • OPTT 100.00

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

Share on Social Networks: